New patent issued for core rare disease target indication for crofelemer

Jaguar has approximately 200 patents issued and pending

Jaguar is supporting investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of short bowel syndrome (SBS) and microvillus inclusion disease (MVID), an ultrarare CDD, in the US, EU, and Middle East/North Africa regions, with proof-of-concept results expected before the end of 2024 and throughout 2025

"The Critical Minerals and ZEO Company"

Live-streaming viewership is up 10% from Q2 2023 to 8.5 billion hours watched

Data Collection and Analysis of Emissions Including Sulphur Oxides, Nitrogen Oxides, and Carbon Dioxide to Support Compliance with MARPOL Annex 6 Regulations

Contract Expands American Robotics' Reach into Strategically Important Ports and Logistics Markets

Positions American Robotics for Significant Market Expansion and Future Growth Opportunities Potentially with U.S. Federal Program of Record Contracts That are Typically Approved for Long Term Funding

WWT to Resell ARIA Cybersecurity Zero Trust PROTECT™ Solution

• SOCIÉTÉ GÉNÉRALE ACQUERRA 75 % DE REED MANAGEMENT SAS (« REED »)

• À LA CLÔTURE DE LA TRANSACTION, LE FINANCEMENT DES INVESTISSEMENTS PRÉVUS PAR REED SERAIT ASSURÉ, Y COMPRIS UN FINANCEMENT DE 35 MILLIONS D'EUROS DANS LE CADRE DU PARTENARIAT AVEC LOOP